Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
83.63
-0.25 (-0.30%)
At close: Jul 30, 2026, 4:00 PM EDT
83.66
+0.03 (0.04%)
After-hours: Jul 30, 2026, 7:34 PM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$30,419
Profits / Employee
-$835,670
Market Cap
8.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 594 | 157 | 35.93% | 594 | 0 |
| Dec 31, 2024 | 437 | 147 | 50.69% | 437 | 0 |
| Dec 31, 2023 | 290 | 80 | 38.10% | 290 | 0 |
| Dec 31, 2022 | 210 | 67 | 46.85% | 210 | 0 |
| Dec 31, 2021 | 143 | 50 | 53.76% | 143 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,402 |
| Corcept Therapeutics | 730 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
CRNX News
- 3 days ago - Crinetics downgraded to Neutral from Buy at UBS - TheFly
- 9 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI) - GlobeNewsWire
- 9 days ago - Crinetics Pharmaceuticals Proxy statement: Proxy filing - Filings
- 9 days ago - Crinetics Pharmaceuticals Slides: Corporate presentation - Filings
- 20 days ago - Crinetics Pharmaceuticals Proxy statement: Proxy filing - Filings
- 22 days ago - Crinetics downgraded to Hold from Buy at Stifel - TheFly
- 22 days ago - How to Ride the $2.6 Trillion Merger Boom With High-Growth Stocks - Barrons
- 23 days ago - Crinetics downgraded to In Line from Outperform at Evercore ISI - TheFly